APVO Average Annual Return Since 2016
APVO Average Annual Return Chart Since 2016
Growth of $10,000.00
Without Dividends Reinvested Into APVO

Also see:
• APVO stock yearly return 2017
• APVO stock yearly return 2018
• APVO stock yearly return 2019
• APVO stock yearly return 2020
• APVO stock yearly return 2021
• APVO stock yearly return 2022
• APVO stock yearly return 2023
• APVO stock yearly return 2024
• APVO stock yearly return 2025
• APVO YTD return
Average Annual Return Benchmarks
Compare APVO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
APVO Share Performance
APVO Average Annual Return Table Since 2016
Start date: 07/21/2016
End date: 04/17/2026
Start price/share: $65,640,960.00
End price/share: $5.28
Dividends collected/share: $0.00
Total return: -100.00%
APVO Average Annual Return: -81.29%
Starting investment: $10,000.00
Ending investment: $0.00
Years: 9.75


APVO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Aptevo Therapeutics Inc
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, are developed using its ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is developed using its ADAPTIR-FLEX modular protein technology platform. The APVO average annual return since 2016 is shown above.

The Average Annual Return on the APVO average annual return since 2016 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether APVO average annual return since 2016 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the APVO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
APVO Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree APVO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Aptevo Therapeutics (APVO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

APYX Average Annual Return
AQST Average Annual Return
ARAY Average Annual Return
ARCT Average Annual Return
ARDT Average Annual Return
ARDX Average Annual Return
ARQT Average Annual Return
ARTL Average Annual Return
ARTV Average Annual Return
ARVN Average Annual Return
More Healthcare companies »
 

APVO Average Annual Return Since 2016 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.